WOLVES HAND, Towns, PostPrime.

■WOLVES HAND＜194A＞Estimated number of shares to be released: 6,468,400 shares (estimated) Release date: 2024/12/17 If the stock price exceeds 1.5 times the public offering price after the listing date, it is possible that shares were sold. Target Shareholders: Estimated shares J-STAR No.3 SS, LP: 1,232,298 shares J-STAR No.3 JF, LP: 638,389 shares J-STAR No.3 JC, LP: 527,951 shares J-STAR No.3 GF,

Fisco JapanDec 17 06:31

Toho, upward revision on 25/2, operating profit 620 billion yen←55 billion yen.

Toho <9602> announced a revision of its financial estimates for the fiscal year ending February 2025. Operating revenue was revised upward from 280 billion yen to 297 billion yen, and operating profit from 55 billion yen to 62 billion yen. With major hits in the film business such as "Crazy Rich House," "Detective Conan: The Crimson Love Letter," "Kingdom: The General and His Return," "The Last Mile," and the unexpected success of the sequel "Haikyu!! The Huge Dumpsite Showdown" generating box office revenue exceeding 11.5 billion yen from the previous consolidated fiscal year.

Fisco JapanOct 16 05:07

PostPrime: Summary of financial results for the 1st quarter of the fiscal year ending May 2025 [Japanese GAAP] (unconsolidated)

JPXOct 15 14:00 · Announcements

PostPrime: Presentation of financial results for the 1st quarter of the fiscal year ending May 2025

JPXOct 15 14:00 · Announcements

TKP, Hio Den, Takashimaya, Toho (15th)

※The above calendar is only a schedule and may be subject to change due to company circumstances. ---------------------------------------October 15th (Tue) ＜135A＞ VRAIN ＜1401＞ mbs ＜1407＞ West HD ＜1418＞ Interlife ＜1430＞ 1st Co. ＜1434＞ JESCOHD ＜1887＞ Japan Land Development ＜198A＞

Fisco JapanOct 15 05:30

DELTA-P, Rena Science, and others.

<198A>Establishment of a post-main board subsidiary <4598> DELTA-PDFP-10917 and the initiation of case registration for the phase 1/2 clinical trial of VEN in the usa <4889> Renascience Japan Agency for Medical Research and Development (AMED) adoption of the Smart Bio Drug Discovery Research Support Project <7050> Acquisition and subsidiary of the advertising business of Frontier I handled by Cinebridge's stock.

Fisco JapanSep 11 06:30